Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare morphologic variant of bronchiolo-alveolar lung carcinoma characterized by the presence of both mucin and non-mucin producing cells.
Biomarker and diagnostic research for mixed mucinous and nonmucinous bronchioloalveolar adenocarcinoma has been reported in the published literature.
No clinical trials have been registered for mixed mucinous and nonmucinous bronchioloalveolar adenocarcinoma.
2 publications have been identified in PubMed for mixed mucinous and nonmucinous bronchioloalveolar adenocarcinoma. Research spans Diagnostic / Biomarker (50%) and Gene Therapy / Novel Therapeutics (50%).
Hamdy NM (2025). [PMID: 40646269](https://pubmed.ncbi.nlm.nih.gov/40646269/). *Scientific reports*. [Gene Therapy / Novel Therapeutics]
Tatcı E (2024). [PMID: 39373141](https://pubmed.ncbi.nlm.nih.gov/39373141/). *Molecular imaging and radionuclide therapy*. [Diagnostic / Biomarker]
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 8:32 PM UTC